Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer.

Michele KlainValeria GaudieriMario PetrettaEmilia ZampellaGiovanni StortoCarmela NappiCarlo BuonerbaFelice CrocettoRosj GallicchioFabio VolpeLeonardo PaceMartin SchlumbergerAlberto Cuocolo

Published in: Future science OA (2021)

Patients with more lesions at 18F-fluorocholine PET/CT than at bone scintigraphy had a poor prognosis. The combined imaging approach could be useful to predict outcome after 223radium therapy.

Keyphrases

pet ct
poor prognosis
positron emission tomography
prostate cancer
computed tomography
long non coding rna
bone mineral density
high resolution
magnetic resonance imaging
soft tissue
magnetic resonance
mass spectrometry
cell therapy
photodynamic therapy
smoking cessation